An unusual case of Wegener's granulomatosis with tongue involvement. 2009

Ayşe Yilmaz, and Serpil Ocal, and Engin Sezer, and Handan Inönü, and Hasibe Yemenici, and Zehra Seyfikli
Department of Chest Diseases, Faculty of Medicine, Gaziosmanpaşa University, Tokat, Turkey. ayse1106@mynet.com

Wegener's granulomatosis is a type of vasculitis characterized by necrotizing granulomatosis respiratory tract lesions and necrotising glomerulonephritis. Nasal, lung and renal biopsies and positive antineutrophil cytoplasmic antibody (c-ANCA) analysis is helpful in diagnosis. Early diagnosis and treatment is critical in prognosis. A 42 years-old male had dyspnea, coughing, hemoptysis, fatigue, loss of appetite, night sweating and arthralgia. Violaceous palpable, purpuric lesions were detected on the sublingual region of the mouth. On chest X-ray, there was nonhomogeneous infiltration in the parenchyma of both lungs. There was alveolar density involving upper lobes of both lungs detected in thoracal computerized tomography as well as patchy densities on the right lung upper-middle lobes. A nasal mucosa biopsy showed strongly destructive vasculitis. c-ANCA test was positive. We report an unusual case with Wegener's granulomatosis, characterized by a rare presentation of tongue involvement and atypical lung radiology with alveolar opacity.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013902 Radiography, Thoracic X-ray visualization of the chest and organs of the thoracic cavity. It is not restricted to visualization of the lungs. Thoracic Radiography,Radiographies, Thoracic,Thoracic Radiographies
D014059 Tongue A muscular organ in the mouth that is covered with pink tissue called mucosa, tiny bumps called papillae, and thousands of taste buds. The tongue is anchored to the mouth and is vital for chewing, swallowing, and for speech. Tongues
D014890 Granulomatosis with Polyangiitis A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN. Granulomatosis, Wegener's,Wegener Granulomatosis,Wegener's Granulomatosis,Granulomatosis with Polyangiitides,Granulomatosis, Wegener,Polyangiitides, Granulomatosis with,Polyangiitis, Granulomatosis with,with Polyangiitides, Granulomatosis,with Polyangiitis, Granulomatosis
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D019268 Antibodies, Antineutrophil Cytoplasmic Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as specific markers for GRANULOMATOSIS WITH POLYANGIITIS and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA (cytoplasmic), p-ANCA (perinuclear), and atypical ANCA. ANCA,Anti-Neutrophil Cytoplasmic Autoantibodies,Anti-Neutrophil Cytoplasmic Autoantibody,Antineutrophil Cytoplasmic Antibodies,Neutrophil Cytoplasmic Autoantibodies,Neutrophil Cytoplasmic Autoantibody,c-ANCA,p-ANCA,Anti-Neutrophil Cytoplasmic Antibodies,Anti-Neutrophil Cytoplasmic Antibody,Antineutrophil Cytoplasmic Antibody,Anti Neutrophil Cytoplasmic Antibodies,Anti Neutrophil Cytoplasmic Antibody,Anti Neutrophil Cytoplasmic Autoantibodies,Anti Neutrophil Cytoplasmic Autoantibody,Antibody, Anti-Neutrophil Cytoplasmic,Antibody, Antineutrophil Cytoplasmic,Autoantibody, Anti-Neutrophil Cytoplasmic,Autoantibody, Neutrophil Cytoplasmic,Cytoplasmic Antibody, Anti-Neutrophil,Cytoplasmic Antibody, Antineutrophil,Cytoplasmic Autoantibody, Anti-Neutrophil,Cytoplasmic Autoantibody, Neutrophil,c ANCA,p ANCA

Related Publications

Ayşe Yilmaz, and Serpil Ocal, and Engin Sezer, and Handan Inönü, and Hasibe Yemenici, and Zehra Seyfikli
January 1997, Nephron,
Ayşe Yilmaz, and Serpil Ocal, and Engin Sezer, and Handan Inönü, and Hasibe Yemenici, and Zehra Seyfikli
February 1991, Scottish medical journal,
Ayşe Yilmaz, and Serpil Ocal, and Engin Sezer, and Handan Inönü, and Hasibe Yemenici, and Zehra Seyfikli
March 1998, The Medical journal of Malaysia,
Ayşe Yilmaz, and Serpil Ocal, and Engin Sezer, and Handan Inönü, and Hasibe Yemenici, and Zehra Seyfikli
November 1978, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
Ayşe Yilmaz, and Serpil Ocal, and Engin Sezer, and Handan Inönü, and Hasibe Yemenici, and Zehra Seyfikli
October 2014, QJM : monthly journal of the Association of Physicians,
Ayşe Yilmaz, and Serpil Ocal, and Engin Sezer, and Handan Inönü, and Hasibe Yemenici, and Zehra Seyfikli
September 1980, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
Ayşe Yilmaz, and Serpil Ocal, and Engin Sezer, and Handan Inönü, and Hasibe Yemenici, and Zehra Seyfikli
January 1997, The Indian journal of chest diseases & allied sciences,
Ayşe Yilmaz, and Serpil Ocal, and Engin Sezer, and Handan Inönü, and Hasibe Yemenici, and Zehra Seyfikli
January 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Ayşe Yilmaz, and Serpil Ocal, and Engin Sezer, and Handan Inönü, and Hasibe Yemenici, and Zehra Seyfikli
January 1976, Bulletin des societes d'ophtalmologie de France,
Ayşe Yilmaz, and Serpil Ocal, and Engin Sezer, and Handan Inönü, and Hasibe Yemenici, and Zehra Seyfikli
January 2022, Revista de gastroenterologia de Mexico (English),
Copied contents to your clipboard!